Related Experiment Video
Updated: Sep 23, 2025

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
Published on: January 26, 2015
Dynamin-related protein 1 differentially regulates FcεRI- and substance P-induced mast cell activation
Ying Wang1, Mang Yu1, Kazufumi Matsushita2
1Department of Pathology, Stanford University School of Medicine, Stanford, Calif.
Background:
The mitochondrial fission protein dynamin-related protein 1 (Drp1) has been suggested to regulate mast cell (MC) activation by certain stimuli in vitro, but its functions in MCs activated by various stimuli in vivo have not yet been examined.
Objective:
We sought to analyze Drp1 function in both mouse and human MCs.
Methods:
We used human peripheral blood-derived cultured MCs and 2 genetic mouse models in which MCs were depleted of Drp1: Drp1fl/flMcpt5cre+/- mice and Drp1fl/flCpa3cre+/- mice.
Results:
In mice, Drp1 depletion enhanced FcεRI-induced MC activation while suppressing substance P-stimulated MC activation in vitro and in vivo. This was also true in human peripheral blood-derived cultured MCs in vitro after pharmacologic inhibition of Drp1.
Conclusion:
Drp1 differentially regulates MC activation by various stimuli. Promoting Drp1 activation might therefore represent a novel therapy for suppressing IgE-dependent MC activation. Further, inhibiting Drp1 activation might mitigate other MC-dependent responses, such as those induced by substance P.
Insights
Dynamin-related protein 1 (Drp1) differentially regulates mast cell activation. Inhibiting Drp1 may treat IgE-mediated responses, while promoting it could suppress substance P-induced mast cell activation.
Area of Science:
- Immunology
- Cell Biology
- Mitochondrial Dynamics
Background:
- Mitochondrial fission protein dynamin-related protein 1 (Drp1) role in mast cell (MC) activation is unclear.
- Previous studies suggested Drp1 regulates MC activation by specific stimuli in vitro.
Purpose of the Study:
- To investigate Drp1 function in both mouse and human mast cells.
- To elucidate Drp1's role in mast cell activation by diverse stimuli in vivo.
Main Methods:
- Utilized human peripheral blood-derived cultured mast cells.
- Employed two genetic mouse models with mast cell-specific Drp1 depletion (Drp1fl/flMcpt5cre+/- and Drp1fl/flCpa3cre+/- mice).
- Assessed mast cell activation in vitro and in vivo.
Main Results:
- Drp1 depletion enhanced FcεRI-induced mast cell activation in mice.
- Drp1 depletion suppressed substance P-stimulated mast cell activation in mice, in vitro and in vivo.
- Pharmacologic Drp1 inhibition mimicked these effects in human mast cells.
Conclusions:
- Drp1 plays a differential role in regulating mast cell activation based on the stimulus.
- Enhancing Drp1 activity could be a therapeutic strategy for IgE-dependent mast cell activation.
- Inhibiting Drp1 may offer a therapeutic approach for conditions involving substance P-mediated mast cell responses.
Related Concept Videos
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Actin Filament Depolymerization
In F-actin, the ADF/cofilin proteins...

